* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download IABP
Survey
Document related concepts
Cardiac contractility modulation wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Drug-eluting stent wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Cardiac surgery wikipedia , lookup
Aortic stenosis wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
History of invasive and interventional cardiology wikipedia , lookup
Coronary artery disease wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Transcript
Intra-aortic baloon pumps what, who, why why why? Daniel Lovric Fellow, CVICU Auckland City Hospital Auckland Region ICU Study Day 30th October 2014 IABP – What is it? Mechanical hemodynamic support device Two principal parts Mobile Console Flexible catheter with baloon How does it work? Balloon is advanced through the femoral artery to descending thoracic aorta Ideal placement is 1-2cm distal of the origin of left subclavian artery and above the origin of renal arteries Inflation triggered either by ECG (R wave) or Pressure waveform Inflation happens in diastole Deflated during systole Should occupy around 85-90% of cross-sectional area Multiple theoretical benefits How does it work? Theoretical benefits – Two basic principles Increasing aortic Decreasing end-diastolic diastolic pressure augments aortic pressure reduces coronary blood flow heart’s afterload Physiological effects Hanlon-Pena et al, AJCC 2011 Reduction in LV workload Reduction in LV workload Commencement of IABP pulsation Reduction in left ventricular pressure Reduction in left ventricular stroke work Increase in left ventricular stroke volume Schreuder et al, Ann Thorac Surg 2005 Augmented coronary flow Conficting evidence Inflation of the balloon diastolic pressure and diastolic perfusion pressure gradient (Port, JACC 1984; Williams, Circ 1982) Animals with normal systemic blood pressure myocardial oxigen consumption, no change in coronary flow (Kern, Am Heart J 1999) Coronary flow measurements pre-stenotic flow (MacDonald, Am J Cardiol 1987; Kern, Circ 1991) post-stenotic flow (MacDonald, Am J Cardiol 1987; Gewirtz, Am J Cardiol 1982) Angina symptoms (Folland, Circ 1991) “Artificial myoconservation” (Ohman, Circ 1994) stimulation of collateral circulation (Ohman, Circ 1994; Fuchs, Circ 1983) Augmented coronary flow Laplace’s Law Deflation of the balloon end-diastolic pressure wall stress myocardial oxygen demand How it begun... 1959 – Kantrowitz described the principle of counterpulsation 1962 – Moulopoulos (Cleveland Clinic) described the modern intra-aortic counterpulsation device - carbon dioxide - R wave timing 1971 – Krakauer & Kantrowitz describe series of 30 pts in cardiogenic shock 2° to STEMI treated with IABP - 25 of 30 pts achieved hemodynamic stabilisation and reversal of shock 1973 – Successful use of IABP in weaning of cardiopulmonary bypass published by two different groups 1980 – Development of percutaneous catheter introduction Moulopoulos et al, Am Heart J 1962; Goldberg et al, NEJM 1999; Antman et al, Circulation 2008 Buckley et al, Circ 1973; Housman et al, JAMA 1973; Bergman et al, A. Th. Surg 1980; Subramanian et al, Circ 1980 ... and took hold 1959 – Kantrowitz described the principle of counterpulsation 1962 – Moulopoulos (Cleveland Clinic) described the modern intra-aortic counterpulsation device - carbon dioxide - R wave timing 1986 – 1997 overall ~20% of patients received IABP suport for cardiogenic shock due to MI 1997 – 42% of patients Moulopoulos et al, Am Heart J 1962; Goldberg et al, NEJM 1999; Antman et al, Circulation 2008 Buckley et al, Circ 1973; Housman et al, JAMA 1973; Bergman et al, A. Th. Surg 1980; Subramanian et al, Circ 1980 Randomized trials IABP in STEMI Randomized trials IABP in STEMI Analysis of trials IABP in STEMI 1009 patients No change in 30 day mortality No change in LVEF at follow-up Stroke rate by 2% (p=0.03) Bleeding by 6% (p=0.02) Sjauw et al. EHJ 2009 Analysis of trials IABP in STEMI with cardiogenic shock 10529 patients Thrombolysis studies showed absolute mortality decrease of 18% (p<0.0001) Primary PCI studies showed absolute mortality increase of 6% (p<0.0008) Revascularization rate IABP 39% vs control 9% (p<0.001) Sjauw et al. EHJ 2009 IABP SHOCK II Trial Designed to affirm guidelines 37 centres, 600 patients 240 primary end-points Overall 30 day mortality of 40% Thiele et al. NEJM 2012 In cardiac surgery Pre-operative IABP in high risk CABG patients 110 hemodynamically stable subjects, LVEF <35% Vent. wean Discharge Ranucci et al. Crit Care Med 2013 In high-risk PCI – BCIS-1 301 patients with severe LV dysfunction (EF<30%) and extensive coronary disease Routine IABP placement before PCI in treatment arm Primary end-point was MACCE at discharge and 6 months P=0.03 Long-term follow-up by tracking UK statistics databases Perera et al. JAMA 2010, Circ 2013 Indications What’s left? Acute mitral regurgitation (Ic) Ventricular septal defect as a complication of MI (Ic) Intractable ventricular arrhythmias (IIa) Unstable angina refractory to medical therapy (IIa) Decompensated systolic HF as bridge to mechanical support or transplant (IIb) Patients following cardiac surgery with low cardiac output unresponsive to pharmacologic therapy Fotopoulos et al. Heart 1999; Ferguson et al, JACC 2001 Contraindications Aortic regurgitation (more than mild) Aortic dissection Aneurysm or other anatomical disease of aorta Severe PVD Lack of experience with management Will not work in distributive shock (sepsis) Will not work in a setting of low CI and tachyarrhythmias Positioning Should be ~2 cm below the origin of left subclavian artery 3-4mm metalic density 2cm bellow the top of aortic knob 2nd – 3rd intercostal space anteriorly Positioning Should be ~2 cm below the origin of left subclavian artery 2cm above carina 1-2cm above PAC Kim et al, Anesth Analg 2007 Positioning Should be ~2 cm below the origin of left subclavian artery IABP Timing Determines periods of inflation and deflation during cardiac cycle Criticaly important for achieving beneficial hemodynamic effects Newer systems can adjust timing completely automatically Conventional Timing Studied and used in practice since the beginning of IABC Both inflation and deflation occur within diastole Inflation Deflation Timed to commence immediately prior or at the time of AV closure (dictrotic notch) Timed at onset of systole Should occur before ejection Isovolumetric contraction phase Timing Errors Early inflation before AV closure LV forced to eject against inflated balloon, premature closure of AV Afterload Oxygen demand Stroke volume to 20% Aortic regurgitation may appear Trost et al, Am J Cardiol 2006 Timing Errors Late inflation after dicrotic notch – AV closure Augmentation Trost et al, Am J Cardiol 2006 Timing Errors Early deflation Before end of diastole, loss of sharp V diastolic pressure trace Augmentation May promote retrograde arterial flow from the coronaries and carotids Trost et al, Am J Cardiol 2006 Timing Errors Late deflation After begining of systole during ejection phase End-diastolic pressure Afterload Oxygen demand LV workload Trost et al, Am J Cardiol 2006 Real-time Timing R wave deflation Deflation occurs in early systole Safe when ≥50% of IABP volume is removed before the start of ejection 2-part potential effect Delayed opening of AV brings prolongation of isovolumetric contraction Length of ejection and stroke volume increased more than in conventional Preferred method when arrhythmia is present Hanlon-Pena et al, AJCC 2011 Complications During insertion Unable to pass the catheter up the aorta Arterial dissection or rupture Retroperitoneal bleeding or damage to adjacent structures Complications During use Distal limb ischemia Poor supply to LSCA/renal arteries/mesenteric arteries Balloon rupture and gas embolism Thromboembolism Haemolysis & Thrombocytopenia Complications On removal Inability to remove the catheter Bleeding Embolism Pseudoaneurysm AV fistula Final thoughts IABP was overutilised in the past It is significantly falling out of favour recently Physiologicaly sound principle, but difficult to implement properly It’s future seems grim... Due to arrival of new mechanical assist therapies Thank you...